About MDB Capital Holdings, LLC - Class A common (MDBH)
MDB Capital Holdings, LLC is a public company that focuses on providing innovative financial solutions, particularly in the technology and biomedical sectors. The company specializes in facilitating capital formation and investment opportunities for early-stage companies by leveraging its expertise in investment banking and venture capital. It aims to bridge the gap between cutting-edge innovation and market access, offering a range of services including advisory, fundraising, and strategic guidance to help its clients navigate the complexities of the financial landscape and achieve sustainable growth. Through its unique approach, MDB Capital Holdings supports the development of transformative technologies and advancements in various industries. Read More
Addison, TX, Nov. 09, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, will host a Zoom webinar on Tuesday, November 17, 2026 at 4:30 p.m. Eastern Time to provide an operational update for the quarter ended September 30, 2026, and subsequent developments. A press release detailing the updates will be issued prior to the call.
New analysis examines why invention provenance, documentation, and ownership records are becoming increasingly important for companies developing AI-assisted innovations
Collaboration will strengthen the Rising Stars platform through structured intellectual property diligence, commercialization-focused assessments, and year-round founder support
PatentVest's newest PV Pulse analysis finds Apple's and Microsoft's AI smart glasses–relevant patent portfolios outrank Google's, Snap's, and Samsung's — despite neither company selling an AI smart glasses product
Addison, TX, July 30, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, will host a Zoom webinar on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time to provide an operational update for the quarter ended June 30, 2026, and subsequent developments. A press release detailing the updates will be issued prior to the call.
New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and infrastructure
Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical legal guidance on the technologies and legal developments reshaping intellectual property.
Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1."
Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO & Co-Founder, Chris Marlett, will present live at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT at the Bellagio Resort & Hotel in Las Vegas, Nevada.
· New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning.
· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.
Dallas, TX, April 29, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse: “The Last 20%: Retatrutide, the Glucagon Paradox, and the Race to Own Surgery-Level Weight Loss Without Surgery.”
Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.”
Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries.
Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing the results will be issued prior to the call.
Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms.
MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service